Healthy Skepticism Library
Items published during the years 2000 to 2009
There are 14385 items in the Healthy Skepticism Library that were published during the years 2000 to 2009.
Page 105 of 144 pages ‹ First < 103 104 105 106 107 > Last ›
HSL6091
Brouneus F, Dahlin A, Beermann B.
Press coverage and sales of Xenical in Sweden, 1998-2000.
Eur J Clin Pharmacol 2005 Jun 01; 61:(4):285-9
http://www.springerlink.com/content/h74829p313380064/
HSL6092
Mbongue TB, Sommet A, Pathak A, Montastruc JL.
'Medicamentation' of society, non-diseases and non-medications: a point of view from social pharmacology.
Eur J Clin Pharmacol 2005 Jun 01; 61:(4):309-13
http://www.springerlink.com/content/t212237555u30773/
HSL1619
Shenfield G.
Prescribers and drug withdrawals
Aust Prescr 2005 Jun; 28:54-5
HSL1646
Brodkey AC.
The role of the pharmaceutical industry in teaching psychopharmacology: a growing problem.
Acad Psychiatry 2005 Sum; 29:(2):222-9
http://ap.psychiatryonline.org/cgi/content/full/29/2/222
HSL2070
Freudenberg N.
Public health advocacy to change corporate practices: implications for health education practice and research.
Health Educ Behav 2005 Jun; 32:(3):298-319
http://heb.sagepub.com/cgi/reprint/32/3/298
HSL2113
Pouye A, Dia D, Sow PS, Yacouba H, Ndour CT, Soumare M, Ciss M, Moreira Diop T.
[Prescription of morphinics in the management of pain in Dakar teaching hospitals]
Bull Soc Pathol Exot. 2005 Jun; 98:(2):118-20
HSL2114
Belongia EA, Knobloch MJ, Kieke BA, Davis JP, Janette C, Besser RE.
Impact of statewide program to promote appropriate antimicrobial drug use.
Emerg Infect Dis 2005 Jun; 11:(6):912-20
http://www.cdc.gov/ncidod/EID/vol11no06/05-0118.htm
HSL2442
King T.
The escalating demand for long-term care.
Can Nurse 2005 Jun; 101:(6):11-5
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=16121471&query_hl=10
HSL3599
Wilmshurst JM, van Toorn R, Newton CR.
Withdrawal of parenteral phenobarbitone--implications for resource-poorcountries.
S Afr Med J 2005 Jun 01; 95:(6):422-3
http://blues.sabinet.co.za/WebZ/Authorize?sessionid=0:autho=pubmed:password=pubmed2004&/AdvancedQuery?&format=F&next=images/ejour/m_samj/m_samj_v95_n6_a17.pdf
HSL3744
Stern SR.
Messages from teens on the big screen: smoking, drinking, and drug use in teen-centered films.
J Health Commun 2005 Jun; 10:(4):331-46
http://journalsonline.tandf.co.uk/(viegs145wlhjoyy4gtnaul45)/app/home/contribution.asp?referrer=parent&backto=issue,6,9;journal,6,55;linkingpublicationresults,1:100673,1
HSL5061
Fugh-Berman A.
The corporate coauthor.
J Gen Intern Med 2005 Jun; 20:(6):546-8
http://www.blackwell-synergy.com/doi/abs/10.1111/j.1525-1497.2005.05857.x
HSL6995
Glinert LH, Schommer JC.
Television advertisement format and the provision of risk information about prescription drug products().
Res Social Adm Pharm 2005 Jun; 1:(2):185-210
HSL6996
Glinert LH.
TV commercials for prescription drugs: A discourse analytic perspective.
Res Social Adm Pharm 2005 Jun; 1:(2):158-84
HSL8034
Schommer JC, Hansen RA.
The study of direct-to-consumer advertising for prescription drugs.
Res Social Adm Pharm 2005 Jun; 1:(2):348-68
HSL8035
Hansen RA, Droege M.
Methodological challenges surrounding direct-to-consumer advertising research--the measurement conundrum.
Res Social Adm Pharm 2005 Jun; 1:(2):331-47
HSL8036
Mintzes B, Barer M, Lexchin J, Bassett KL.
Introduction of direct-to-consumer advertising of prescription drugs in Canada: an opinion survey on regulatory policy.
Res Social Adm Pharm 2005 Jun; 1:(2):310-30
HSL8037
Sewak SS, Wilkin NE, Bentley JP, Smith MC.
Direct-to-consumer advertising via the Internet: the role of Web site design.
Res Social Adm Pharm 2005 Jun; 1:(2):289-309
HSL8038
Young HN, Lipowski EE, Cline RJ.
Using social cognitive theory to explain consumers' behavioral intentions in response to direct-to-consumer prescription drug advertising.
Res Social Adm Pharm 2005 Jun; 1:(2):270-88
HSL8039
Liu Y, Doucette WR, Farris KB, Nayakankuppam D.
Drug information-seeking intention and behavior after exposure to direct-to-consumer advertisement of prescription drugs.
Res Social Adm Pharm 2005 Jun; 1:(2):251-69
HSL8040
Schommer JC, Singh RL, Hansen RA.
Distinguishing characteristics of patients who seek more information or request a prescription in response to direct-to-consumer advertisements.
Res Social Adm Pharm 2005 Jun; 1:(2):231-50
HSL8041
Shah MB, Bentley JP, McCaffrey DJ 3rd, Kolassa EM.
Direct-to-consumer advertising and the patient-physician relationship.
Res Social Adm Pharm 2005 Jun; 1:(2):211-30
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&cmd=Retrieve&dopt=AbstractPlus&list_uids=17138475&query_hl=30&itool=pubmed_DocSum
HSL8042
Hansen RA, Schommer JC, Cline RR, Hadsall RS, Schondelmeyer SW, Nyman JA.
The association of consumer cost-sharing and direct-to-consumer advertising with prescription drug use.
Res Social Adm Pharm 2005 Jun; 1:(2):139-57
HSL8043
Desselle SP.
The interaction of direct-to-consumer prescription drug advertising and stakeholders in the medication use process.
Res Social Adm Pharm 2005 Jun; 1:(2):135-8
HSL12804
Hopkins C.
Research, drug companies differ over male impotence
The Independent Monthly (University of Queensland student newspaper) 2005 Jun18
http://web.archive.org/web/20061224215658/http://gut.bmj.com/cgi/content/full/55/5/643
HSL13292
Miyazaki AD, Grewal D, Goodstein RC.
The Effect of Multiple Extrinsic Cues on Quality Perceptions: A Matter of Consistency
Journal of Consumer Research 2005 Jun; 32:(1):146
http://www.journals.uchicago.edu/doi/abs/10.1086/429606
HSL1601
Brownlee S, Lenzer J.
Spin Doctored: How drug companies keep tabs on physicians.
Slate Magazine 2005 May 31;
http://slate.msn.com/id/2119712/
HSL3767
Berenson A.
Despite vow, drug makers still withhold data.
NY Times (Print) 2005 May 31; :A1,:
HSL20274
Hutchinson JM, Gigerenzer G.
Simple heuristics and rules of thumb: where psychologists and behavioural biologists might meet.
Behav Processes. 2005 May 31; 69:(2):97-124
HSL1596
Opinion .
Health law is essentially flawed
The Sydney Morning Herald 2005 May 30;
http://www.smh.com.au/news/Opinion/Health-law-is-essentially-flawed/2005/05/
HSL1599
Maher S.
Drug companies 'talk up' ailments
The Australian 2005 May 30;
HSL1459
Burton B.
Drug chiefs ponder how to improve industry's reputation
BMJ 2005 May 28; 330:1229
http://bmj.bmjjournals.com/cgi/content/full/330/7502/1229-a
HSL1460
Burton B.
Pfizer Australia is fined for misleading promotion of celecoxib
BMJ 2005 May 28; 330:1230
http://bmj.bmjjournals.com/cgi/content/full/330/7502/1230-b
HSL1597
Pringle E.
TeenScreen: Who Pays for Treatment and Drugs?
Independent Media TV 2005 May 28;
HSL1593
Associated Press.
Novartis Gets FDA Approval for ADHD Drug
Forbes.com 2005 May 27;
HSL1592
Zimmerman R, Tomsho R.
Medical Editor Turns Activist On Drug Trials
The Wall Street Journal 2005 May 26
HSL1594
Rowland C.
Hospitals split over role drug firms play: Involvement in tests raises concerns over integrity of studies
The Boston Globe 2005 May 26
HSL1587
Msnbc .
U.S. suicides decline, but thoughts remain: Vulnerable patients need better treatment, experts say
Reuters 2005 May 24;
HSL1588
Agovino T.
Drug Firms Don't Disclose Enough: Three Pharmaceutical Companies Don't Disclose Enough in Clinical Trial Registry, Editor Says
The Associated Press 2005 May 24
HSL1577
Behar D, Schaller JL.
Letter to the Editor: Drug rep visits actually improve care for patients
American Medical Association News 2005-2005 May-May 23-30;
HSL1591
Dabade G.
Remembering a health campaigner
Deccan Herald 2005 May 23;
HSL5351
Nebeker JR, Hoffman JM, Weir CR, Bennett CL, Hurdle JF.
High rates of adverse drug events in a highly computerized hospital.
Arch Intern Med 2005 May 23; 165:(10):1111-6
http://archinte.ama-assn.org/cgi/content/full/165/10/1111
HSL1586
Carey B.
F.D.A. Considers Implant Device for Depression
The New York Times 2005 May 21;
HSL1589
Berenson A.
Merck's New Boss Inherits a Mess
The New York Times 2005 May 21;
HSL19812
Carter H
New code to clamp down on unethical ghost writing
Medical Observer 2005 May 20
http://www.psychiatryupdate.com.au/news/new-code-to-clamp-down-on-unethical-ghost-writing-
HSL1585
Wilde-mathews A.
Brain Neurostimulation Shown to Relieve Severe Depression for Some: Ruling on Medical Device Examined
THE WALL STREET JOURNAL 2005 May 19
HSL1582
The Associated Press
Pregnancy Warning on Antidepressants
The New York Times 2005 May 18
HSL1580
Henderson D.
Acne drug reduces teen depression: Study looks at link between Accutane, suicidal behavior
The Boston Globe 2005 May 17;
HSL1581
Saul S.
The Marketing and Success of Natrecor
The New York Times 2005 May 17
HSL2674
Johnston I.
Ex-medical journal editor reveals drug firms' dirty tricks
The Scotsman 2005 May 17
http://thescotsman.scotsman.com/index.cfm?id=536012005
HSL1578
Edwards J.
Where There's A Pill, There's A Way
Brandweek.com 2005 May 16;
HSL1579
Schmit J.
Costs, regulations move more drug tests outside USA
USA TODAY 2005 May 16;
HSL1583
Kowalczyk L.
Psychiatry funding questioned: Drug firms aid Mass. General
The Boston Globe 2005 May 14;
HSL1553
Common drugs raise heart threat
BBC News 2005 May 11;
http://news.bbc.co.uk/go/pr/fr/-/1/hi/health/4535697.stm
HSL1555
Silverman E.
Biz Buzz: Actress's on-screen personalities collide at conference
New Jersey Star Ledger 2005 May 11;
HSL1509
Stafford A, Allen L.
Drug companies, doctors face curbs
The Financial Review 2005 May 10;
HSL1511
Allen L.
Fee rise will hit vitamins, medicines
The Financial Review 2005 May 10;
HSL1512
Reuters .
Drug Makers Set Out to Create Ad Guidelines to Improve Image
REUTERS NEWS SERVICE 2005 May 10;
HSL1572
Kaisernetwork.org
Prescription Drugs: PhRMA CEO Tauzin Discusses Drug Industry Image, Reimportation, Other Issues
kaisernetwork.org 2005 May 10;
HSL1576
Dabade G.
Of patents, licences and drug prices
Deccan Herald 2005 May 10;
HSL1510
Frenkel J, Harvey M, McManus G.
$800m boost for cheaper medicine
The Herald Sun 2005 May 9;
HSL1554
Pollack A.
Marketing a Disease, and Also a Drug to Treat It
The New York Times 2005 May 9;
HSL1571
Edelman S.
CONTRA-DECEPTION
The New York Post 2005 May 9;
HSL1584
Connolly C.
Pentagon to Drop Nexium From Its List Of Covered Drugs for Military Personnel 'Purple Pill' Nexium the First to Be Cut
The Washington Post 2005 May 8;
HSL3779
Cohen AF.
[The pharmaceutical industry in uproar]
Ned Tijdschr Geneeskd 2005 May 7; 149:(19):1074
HSL1503
Kaufman M.
Merck CEO Resigns as Drug Probe Continues
The Washington Post 2005 May 6;
HSL1504
Appleby J.
Merck's marketing of Vioxx called misleading
USA TODAY 2005 May 6;
http://www.usatoday.com/printedition/money/20050506/vioxx06.art.htm
HSL1505
Krugman P.
A Serious Drug Problem
The New York Times 2005 May 6;
HSL1508
Reuters .
Regulator slaps Pfizer on Zoloft ads: FDA orders No. 1 drugmaker to halt ads neglecting to warn of antidepressant's fatal side effects.
CNN Money 2005 May 6;
HSL1561
Gottlieb S.
Big Pharma's New Funk
Forbes.com 2005 May 6;
HSL1575
Blumenstyk G.
Universities Fear a California Ruling Could Set a Precedent, Leaving Them Liable for Research Sponsors' Lost Profits
Chronicle of Higher Education 2005 May 6;
HSL19788
Cole L
Medical sponsorship thrown under further scrutiny
Medical Observer 2005 May 6
HSL1506
Waxman HA
Merck Documents Show Aggressive Marketing of Vioxx After Studies Indicated Risk
: United States House of Representatives Commitee on Government Reform Minority Office 2005 May 5
http://www.democrats.reform.house.gov/story.asp?ID=848
HSL1500
Solomon J.
Researchers Tested AIDS Drugs on Children
LA Times 2005 May 4;
HSL1501
Kaufman M.
Clinical Trials of Drugs Fewer, Study Says: Report Also Notes Decline in Number of Principal Investigators in U.S.
The Washington Post 2005 May 4;
HSL1507
Harris G.
Petition Seeks Warning on Anticancer Medication
The New York Times 2005 May 4;
HSL1590
Solomon J.
Government tested AIDS drugs on foster kids: Children not provided with basic legal protection, review finds
The Associated Press 2005 May 4;
HSL1498
Dinant G-J, Mansfield P.
Van zoete koek naar gezonde scepsis: De houding van huisartsen tegenover geneesmiddelenreclame
Huisarts Wet 2005 May 2; 48:(6):304-307
http://vb23.bsl.nl/frontend/framesets/index_henw.asp?custom_product_id=0018-7070&product_id=
HSL1061
Scherer M.
The Side Effects of Truth: In exposing the deadly threat posed by Vioxx, FDA researcher David Graham was serving the public interest. His bosses had other interests in mind.
Mother Jones 2005 May 1
HSL1296
Cutting Edge
Oncology Brand Commercialization: Resource Allocation
2005 May
http://www.pharmaoncologymarketing.com/
HSL1559
Tansey B.
Why doctors prescribe off label
San Francisco Chronicle 2005 May 1;
HSL3712
Diller L.
Fallout from the pharma scandals: the loss of doctors' credibility?
Hastings Cent Rep 2005 May-Jun 01; 35:(3):28-9
HSL3740
Tonkens R.
An overview of the drug development process.
Physician Exec 2005 May-Jun 01; 31:(3):48-52
HSL3755
Hamrin V, Scahill L.
Selective serotonin reuptake inhibitors for children and adolescents with major depression: current controversies and recommendations.
Issues Ment Health Nurs 2005 May 01; 26:(4):433-50
HSL3768
Allen TS Jr, Henderson JH Jr.
Merck VIOXX "warning" is questioned.
Tex Med 2005 May 01; 101:(5):5-6
HSL3774
Thacker PD.
Pharmaceutical data elude researchers.
Environ Sci Technol 2005 May 1; 39:(9):193A-194A
HSL3783
Ahlborn H, Henderson S, Davies N.
No immediate pain relief for the pharmaceutical industry.
Curr Opin Drug Discov Devel 2005 May 01; 8:(3):384-91
HSL3784
Torr-Brown S.
Advances in knowledge management for pharmaceutical research and development.
Curr Opin Drug Discov Devel 2005 May 01; 8:(3):316-22
HSL3785
Gund P, Maliski E, Brown F.
Editorial overview: whither the pharmaceutical industry?
Curr Opin Drug Discov Devel 2005 May 01; 8:(3):296-7
HSL3786
Longstaff C, Thelwell C, Whitton C.
The poor quality of streptokinase products in use in developing countries.
J Thromb Haemost 2005 May 01; 3:(5):1092-3
http://www.ncbi.nlm.nih.gov/entrez/utils/lofref.fcgi?PrId=3046&uid=15869616&db=pubmed&url=http://dx.doi.org/10.1111/j.1538-7836.2005.01271.x
HSL3788
MacDonald A.
Ethics committee approval of multicentre studies.
Intern Med J 2005 May 01; 35:(5):311-2
http://www.blackwell-synergy.com/doi/abs/10.1111/j.1445-5994.2005.00827.x
HSL3805
Ashcroft DM, Quinlan P, Blenkinsopp A.
Prospective study of the incidence, nature and causes of dispensing errors in community pharmacies.
Pharmacoepidemiol Drug Saf 2005 May 01; 14:(5):327-32
http://www3.interscience.wiley.com/cgi-bin/abstract/109608242/ABSTRACT
HSL4807
Shah RV, Albert TJ, Bruegel-Sanchez V, Vaccaro AR, Hilibrand AS, Grauer JN.
Industry support and correlation to study outcome for papers published in Spine.
Spine 2005 May 1; 30:(9):1099-104
http://meta.wkhealth.com/pt/pt-core/template-journal/lwwgateway/media/landingpage.htm?issn=0362-2436&volume=30&issue=9&spage=1099
HSL4947
Dallegri F, Bertolotto M, Ottonello L.
A review of the emerging profile of the anti-inflammatory drug oxaprozin.
Expert Opin Pharmacother 2005 May 01; 6:(5):777-85
http://www.ncbi.nlm.nih.gov/entrez/utils/lofref.fcgi?PrId=3204&uid=15934904&db=PubMed&url=http://www.ashley-pub.com/doi/abs/10.1517/14656566.6.5.777
HSL4948
Silay YS, Jankovic J.
Emerging drugs in Tourette syndrome.
Expert Opin Emerg Drugs 2005 May 01; 10:(2):365-80
http://www.expertopin.com/doi/abs/10.1517/14728214.10.2.365
HSL4950
Austin S.
Drug Discovery Technology Europe 2005 - IBC's Ninth Annual Conference and Exhibition.
IDrugs 2005 May 01; 8:(5):370-3
HSL4951
Ulmer JB.
DNA vaccines forum: how to enhance DNA vaccines safety and potency?
IDrugs 2005 May 01; 8:(5):357-9
HSL1636
Offit PA.
Why are pharmaceutical companies gradually abandoning vaccines?
Health Aff (Millwood) 2005 May-Jun; 24:(3):622-30
http://content.healthaffairs.org/cgi/content/full/24/3/622
HSL2110
McMullin ST, Lonergan TP, Rynearson CS.
Twelve-month drug cost savings related to use of an electronic prescribing system with integrated decision support in primary care.
J Manag Care Pharm 2005 May; 11:(4):322-32
HSL2119
Doucette WR, Andersen TN.
Practitioner activities in patient education and drug therapy monitoring for community dwelling elderly patients.
Patient Educ Couns 2005 May; 57:(2):204-10
http://www.sciencedirect.com/science?_ob=ArticleURL&_udi=B6TBC-4CTN99X-1&_coverDate=05%2F31%2F2005&_alid=305102447&_rdoc=1&_fmt=&_orig=search&_qd=1&_cdi=5139&_sort=d&view=c&_acct=C000050221&_version=1&_urlVersion=0&_userid=10&md5=e37975b79e203a300424ac0c151ffb6b
HSL2120
Mebane FE.
The importance of news media in pharmaceutical risk communication: proceedings of a workshop.
Pharmacoepidemiol Drug Saf 2005 May; 14:(5):297-306
http://www3.interscience.wiley.com/cgi-bin/abstract/109596257/ABSTRACT
Page 105 of 144 pages ‹ First < 103 104 105 106 107 > Last ›
